Literature DB >> 19487375

"Dwarf" estrogen receptor in breast cancer and resistance to tamoxifen.

Amy M Fowler, Richard J Santen, D Craig Allred.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19487375     DOI： 10.1200/JCO.2009.21.8776

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  ER-α36, a novel isoform of ER-α66, is commonly over-expressed in apocrine and adenoid cystic carcinomas of the breast.

Authors:  Semir Vranic; Zoran Gatalica; Hao Deng; Snjezana Frkovic-Grazio; Lisa M J Lee; Olga Gurjeva; Zhao-Yi Wang
Journal:  J Clin Pathol       Date:  2010-11-02       Impact factor: 3.411

2.  Estrogen receptor alpha 46 is reduced in tamoxifen resistant breast cancer cells and re-expression inhibits cell proliferation and estrogen receptor alpha 66-regulated target gene transcription.

Authors:  Carolyn M Klinge; Krista A Riggs; Nalinie S Wickramasinghe; Celia G Emberts; David B McConda; Parul N Barry; Joan E Magnusen
Journal:  Mol Cell Endocrinol       Date:  2010-03-17       Impact factor: 4.102

3.  Daidzein-estrogen interaction in the rat uterus and its effect on human breast cancer cell growth.

Authors:  Leonardo Gaete; Andrei N Tchernitchin; Rodrigo Bustamante; Joan Villena; Igor Lemus; Manuel Gidekel; Gustavo Cabrera; Paola Astorga
Journal:  J Med Food       Date:  2012-12-10       Impact factor: 2.786

Review 4.  miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets.

Authors:  Carolyn M Klinge
Journal:  Mol Cell Endocrinol       Date:  2015-02-03       Impact factor: 4.102

5.  Chaperone gp96 mediates ER-α36 cell membrane expression.

Authors:  Junwei Hou; Mengmeng Deng; Xin Li; Weiwei Liu; Xiaoyu Chu; Jing Wang; Feng Chen; Songdong Meng
Journal:  Oncotarget       Date:  2015-10-13

6.  Beta protein 1 homeoprotein induces cell growth and estrogen-independent tumorigenesis by binding to the estrogen receptor in breast cancer.

Authors:  Sidney W Fu; Saurabh P Kirolikar; Erika Ginsburg; Xiaohui Tan; Arnold Schwartz; Samuel J Simmens; Yan-Gao Man; Joseph J Pinzone; Christine Teal; Sanket Awate; Barbara K Vonderhaar; Patricia E Berg
Journal:  Oncotarget       Date:  2016-08-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.